相关实验视频

Updated: Jul 2, 2025

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Published on: February 9, 2014

马拉特1调节PMN-MDSC扩张和免疫抑制,通过p-STAT3在败血症中的无处不在

Yaodong Wang¹, Caiyan Zhang¹, Tingyan Liu¹

¹Department of Critical Care Medicine, Children's Hospital of Fudan University, Shanghai, China.

International journal of biological sciences

|February 22, 2024

概括

败血症触发了髓质衍生抑制细胞 (MDSCs) 的扩张. 长非编码RNA Malat1通过控制STAT3酸化来调节这一过程,为败血症引起的免疫功能障碍提供了潜在的治疗标.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

骨髓系衍生抑制细胞 (MDSCs) 在败血症的发病过程中起着至关重要的作用.
MDSCs的扩张有助于在败血症中持续的炎症-免疫抑制-代谢综合征.
了解MDSC生成机制对于开发败血症治疗方法至关重要.

研究的目的:

阐明在败血症期间产生MDSC的潜在机制.
调查转移相关的肺腺癌转录1 (Malat1) 在MDSC调节中的作用.
确定潜在的治疗点,以调节败血症中免疫状态.

主要方法:

建立一个结结和穿孔败血症小鼠模型.
RNA测序用于识别骨髓细胞中差异表达的基因.
使用马拉特1抑制剂和STAT3酸化抑制剂的体内和体外实验 (Stattic).
检测MDSC比例和评估免疫抑制活性.

主要成果:

多态核-MDSCs (PMN-MDSCs) 在败血症期间显示出动态变化,在晚期增加和激活.
马拉特1的表达与PMN-MDSC扩张和激活相反相关.
马拉特1抑制会加剧败血症的死亡率,而它的下调会增强PMN-MDSC的免疫抑制功能.
马拉特1加速化STAT3的降解,限制PMN-MDSC的分化.
通过抑制PMN-MDSCs,STAT3抑制提高了败血症小鼠的生存率.

结论:

马拉特1是导致败血症的PMN-MDSC生成和功能的关键调节者.
马拉特1-STAT3通路为败血症治疗提供了一个新的治疗点.
针对MDSCs,特别是通过Malat1-STAT3轴,有望改善败血症的免疫状态.

关键词:

实验性的败血症.马拉特是一个国家.由多态核核细胞衍生出来的髓质细胞抑制细胞.在STAT3路径中,在Ubiquitination中使用.

更多相关视频

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Preparation of Myeloid Derived Suppressor Cells MDSC from Naive and Pancreatic Tumor-bearing Mice using Flow Cytometry and Automated Magnetic Activated Cell Sorting AutoMACS

Published on: June 18, 2012

相关概念视频

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...